Alcohol and Your Heart: A Patient's Guide to What the Latest Evidence Says and What It Means for You

For most of my career, patients asked me a version of the same question. “Is a glass of wine with dinner good for my heart?” And for most of my career the honest answer was “probably, in moderation.” That answer has changed. The 2025 American Heart Association scientific statement on alcohol and cardiovascular disease is a real shift in how cardiologists talk about drinking, and this guide walks through what the evidence now says.

Where the J-Curve Idea Came From and Why It’s Weakening

Starting in the late 1980s, large observational studies suggested that light drinkers, about one drink a day for women and up to two for men, had lower rates of heart disease and lower overall mortality than both heavy drinkers and nondrinkers. Plotted out, the curve dipped in the middle, so it got nicknamed the J-curve. Mechanistic work seemed to back it up, showing alcohol raised HDL cholesterol and modestly affected platelet aggregation. Patients heard “a glass of red wine is good for your heart” and ran with it.

The trouble was never the statistics. It was the comparison group. The people who answer “zero drinks per week” aren’t healthy nondrinkers. That group mixes lifelong abstainers with former heavy drinkers who quit because they got sick, people with active illness told to stop, and people on medications that forbid alcohol. Light drinkers, meanwhile, tend to have higher income, better diets, more exercise, and better access to preventive care. Compare the two and light drinkers look healthier. That doesn’t mean alcohol made them healthier.

Mendelian randomization broke the tie, using genetic variants in the ALDH2 and ADH1B genes that influence lifetime drinking as a natural experiment, since those variants aren’t linked to income, diet, or exercise. The 2022 JAMA Network Open study by Biddinger and colleagues applied it to nearly 372,000 UK Biobank participants and found no causal protective effect of light or moderate drinking for coronary heart disease or heart attack. Every level above abstinence carried higher cardiovascular risk, with steeper increases past moderate amounts. Meta-analyses by Stockwell and colleagues found the same from the other direction. The apparent benefit vanishes once former drinkers and sick abstainers are handled properly.

What the 2025 AHA Statement Says

The 2025 AHA scientific statement makes seven main points. Don’t start drinking for cardiovascular benefit. Heavier drinking raises blood pressure, AFib, cardiomyopathy, stroke, and all-cause mortality. The J-curve for light drinking is likely confounded rather than real. Every patient should be screened for alcohol use at every cardiology visit. Patients with hypertension, AFib, or heart failure should be counseled directly to reduce. Alcohol use disorder treatment, including medication, is underused in cardiology. And public health messaging should move away from any-amount-is-fine framing.

The specific language is worth knowing if you’ve read the older 2018 statement, which still left room for the J-curve. For people who don’t drink, “abstinence should not be discouraged, and initiation of alcohol consumption for cardiovascular benefit is not recommended.” For people who drink occasionally, consumption “at the lowest level compatible with the patient’s individual values and social context,” with reduction below current intake considered. For hypertension, reduction to 2 or fewer standard drinks per day for men and 1 or fewer for women, with elimination preferred in resistant hypertension. For AFib, reduction to the lowest tolerated level, citing the Alcohol-AF trial. For heart failure, reduction for everyone and abstinence for suspected or confirmed alcoholic cardiomyopathy. For prior stroke or transient ischemic attack, reduction, with elimination preferred if AFib is also present.

The statement endorses validated screening tools. AUDIT-C is the short one, three questions scored 0 to 12, with scores above 4 in men or 3 in women suggesting heavy or hazardous drinking. The longer AUDIT is the gold standard for deeper screening. The statement also tells cardiologists to either treat alcohol use disorder themselves with the FDA-approved medications (naltrexone, acamprosate, disulfiram) or refer to addiction medicine.

Alcohol and Blood Pressure

A single drink causes a brief drop in blood pressure from vasodilation, then a rebound rise as the alcohol is metabolized. Regular drinking shifts the baseline upward, dose-dependently, starting around 12 grams (one drink) per day. Heavy drinkers at 3 or more drinks daily often run 5 to 10 mmHg higher systolic than nondrinkers.

A 2017 meta-analysis of randomized trials found that cutting back from heavy drinking (more than 6 drinks per day) to moderate or light levels lowered systolic pressure by 3 to 6 mmHg and diastolic by 2 to 4 mmHg. For moderate drinkers at 1 to 3 drinks per day who cut back, the benefit is smaller but still measurable. A patient on three blood pressure medications who goes from 14 drinks per week to 4 often gets a 5 to 10 mmHg systolic drop without changing a single dose.

This is one of the highest-yield things you can do for high blood pressure. Many of my patients try a 4-week trial of abstinence and watch their home readings fall. Most heavy drinkers see meaningful drops within 2 to 4 weeks of substantial reduction, with the full benefit at 3 to 6 months. For more on managing blood pressure overall, see our guide to blood pressure and kidney damage.

Alcohol and Atrial Fibrillation

A 2017 meta-analysis showed AFib risk rose 8 percent for every drink per day, linearly across the range studied, with no threshold below which alcohol stopped raising risk.

The Australian Alcohol-AF trial randomized moderate drinkers, about 17 drinks per week, who had paroxysmal or persistent AFib, to abstinence or continued drinking. Over 6 months the abstinence group had a 53 percent reduction in AFib recurrence. AFib burden, the share of time spent in AFib, dropped from about 8.2 percent to about 5.6 percent. Mean weight also fell about 2 kg, which may have contributed. That trial changed how I counsel AFib patients. Alcohol cessation here has randomized evidence comparable to many medications, so I don’t present it as a soft suggestion.

Binge drinking can also trigger acute AFib in someone with a previously normal rhythm, which is holiday heart syndrome and a common reason for ER visits around holidays and weekends. The AFib usually resolves on its own within 24 to 48 hours of abstinence, though it comes back with the next binge. See our guide to holiday heart syndrome for more. If complete abstinence isn’t realistic for you, substantial reduction still helps.

Alcohol and Coronary Disease

Heavy chronic drinking pushes coronary disease along through several pathways at once. Higher blood pressure stressing the arterial wall. Insulin resistance and weight gain. Direct toxic effects on heart muscle. More arrhythmia, both AFib and sometimes ventricular. Higher triglycerides and a modest LDL rise in some patients.

The proposed mechanisms for light alcohol’s coronary benefit, the HDL increase and the antiplatelet effect, are real but small, and Mendelian randomization shows they don’t translate into clinical coronary protection. The original observational benefit looks like confounding. So don’t drink for heart benefit. If you already drink lightly, the cardiovascular harm at that level is probably small, but the benefit is now considered absent. If you drink heavily, cutting back is one of the highest-yield things available to you.

Alcohol and Heart Failure

Years of heavy drinking, typically 6 or more drinks per day over years, can damage heart muscle directly. The heart dilates, the ejection fraction (the pumping function) drops, and heart failure symptoms follow. That’s alcoholic cardiomyopathy. The diagnosis comes after excluding other causes such as coronary disease, valve disease, viral cardiomyopathy, and infiltrative diseases, with the drinking history as the clue that points you there.

Here’s the encouraging part. Many patients recover substantially or fully with complete abstinence. Ejection fraction can rise 10 to 20 points within 6 to 18 months of stopping in patients who stick with it. The earlier the diagnosis and the more complete the abstinence, the better the recovery. It’s one of the few cardiomyopathies that genuinely reverses. For any heart failure patient, whatever the cause, reducing or eliminating alcohol improves symptoms and slows progression.

Alcohol and Stroke

Heavy drinking raises ischemic stroke risk (a clot in a brain artery) through hypertension, AFib, and accelerated atherosclerosis, and binge drinking can trigger acute AFib that then throws a clot to the brain. Heavy and binge drinking also raise the risk of hemorrhagic stroke (bleeding in or around the brain) through sudden hypertensive spikes, vascular fragility, and effects on platelet function. Light drinking has no proven benefit here either. If you’re at elevated stroke risk from AFib, a prior stroke, or uncontrolled hypertension, cutting back is worth real effort. If you’re on anticoagulation, heavy or binge drinking raises bleeding risk sharply and needs a conversation with your team.

Alcohol and Your Heart Medications

Alcohol interacts with almost every major class of cardiovascular medication, and the safest pattern on any of them is light or no drinking with no binge episodes.

On warfarin the interaction runs both directions. Acute heavy drinking inhibits warfarin metabolism and pushes the INR up, raising bleeding risk; chronic heavy drinking induces enzymes that pull the INR down, raising clot risk. Nobody can dose around that, so aim for consistent light intake, ideally fewer than 7 drinks per week, with no binges. On apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), or edoxaban (Savaysa) the pharmacokinetic interaction is smaller, but heavy or binge drinking still raises bleeding risk substantially, in the gastrointestinal tract where alcohol injures the stomach lining and esophagus, and in the brain where higher blood pressure plus impaired clotting raises hemorrhagic stroke risk. Occasional moderate drinking is generally fine on a DOAC. Binge drinking is not. On aspirin or clopidogrel, alcohol raises gastrointestinal bleeding risk dose-dependently, and adding an NSAID like ibuprofen or naproxen on top is especially dangerous.

Alcohol raises baseline blood pressure, opposing what your antihypertensive is doing, and heavy drinkers often have erratic pressure that won’t respond to dose adjustments because the alcohol load shifts day to day. The acute effect can also drop pressure dangerously alongside vasodilators. ACE inhibitors (lisinopril, ramipril), ARBs like losartan or valsartan, and dihydropyridine calcium channel blockers (amlodipine, nifedipine) can cause lightheadedness or fainting in someone drinking heavily on top of them, and alpha-blockers (doxazosin, terazosin) are especially prone to it.

Statins and alcohol are both handled by the liver, so heavy drinking raises the risk of statin-associated liver enzyme elevations and muscle problems. Not an absolute contraindication, but it earns closer lab monitoring. The bigger issue is established alcoholic fatty liver disease or alcoholic hepatitis, which substantially raise the risk of statin liver toxicity. There the statin dose often comes down, and pravastatin (less liver-metabolized) is sometimes preferred over atorvastatin, rosuvastatin, or simvastatin. On statins without liver disease, moderate drinking is generally tolerated.

Antiarrhythmics are a recurring problem because alcohol is itself proarrhythmic. The drug is trying to prevent AFib episodes, the alcohol is trying to trigger them, and the alcohol tends to win. Amiodarone adds liver toxicity that compounds with alcohol’s, so heavy drinkers on it need liver monitoring more often; see our guide to amiodarone risks and benefits. Flecainide and propafenone are associated with breakthrough AFib and reduced efficacy in drinkers. On sotalol, alcohol’s effect on the QT interval compounds the drug’s own QT prolongation and raises torsades de pointes risk, and dronedarone carries similar concerns.

Diabetes medications add hypoglycemia risk on top of all this. Sulfonylureas (glipizide, glyburide) and insulin can cause severe hypoglycemia with even moderate alcohol on an empty stomach. SGLT2 inhibitors and GLP-1 agonists carry less hypoglycemia risk but have their own interactions worth raising with your prescriber.

What Counts as a Drink, and What Counts as Too Much

A standard US drink holds about 14 grams of pure alcohol. That’s 12 oz of regular beer at about 5 percent, 8 to 9 oz of malt liquor at about 7 percent, 5 oz of wine at about 12 percent, 3 to 4 oz of fortified wine such as port or sherry at 17 to 20 percent, or 1.5 oz of spirits at about 40 percent.

Almost nobody pours that way. Home pours of wine run 6 to 8 ounces, which is 1.2 to 1.6 standard drinks. Cocktails often contain 2 to 3 standard drinks of spirits. Craft beers run 7 to 10 percent alcohol, making one bottle equal to 1.5 to 2 standard drinks. Patients who tell me “one or two glasses of wine a night” are frequently drinking the equivalent of 3 to 4 standard drinks. A few weeks of honest measurement is usually revealing.

US Dietary Guidelines define moderate drinking as up to one drink per day for women and up to two for men. The 2025 AHA statement doesn’t endorse that level as beneficial for the heart, though it doesn’t call it severely harmful either. Heavy drinking is more than 4 drinks per day or 14 per week for men, and more than 3 per day or 7 per week for women, and the cardiovascular harm scales with the dose. Binge drinking is 5 or more drinks within 2 hours for men or 4 or more for women, and even occasional binges carry real risk through AFib, blood pressure spikes, and stroke. Binge pattern is worse than the same total spread out. Fourteen drinks over 7 days is less harmful than 14 drinks on one Saturday night.

How to Cut Back

Vague goals fail. “Cut back” doesn’t work; “no alcohol Monday through Thursday, no more than 2 drinks on each weekend night” does. A workable target for many patients is no more than 7 drinks per week, no more than 2 in any 24-hour period, and at least 3 to 4 alcohol-free days. Track what you actually drink in standard drinks rather than pours, using a notebook, tally marks on a calendar, or an app such as Reframe, DrinkControl, or Drinkaware.

The practical levers are measured pours instead of a heavy hand, lower-alcohol options like lighter beer or wine spritzers, and the non-alcoholic beers and wines, which have improved enormously and give you the social ritual without the cardiovascular effects. Eat when you drink, since food slows absorption and cuts total intake. Avoid drinking alone, which tends to escalate. Name your triggers, the specific settings, emotions, and times of day, and plan for each. For holidays, weddings, and vacations, alternate alcoholic and non-alcoholic drinks and set a hard stop. Don’t lean on alcohol for stress; the short-term relief drives long-term escalation.

Watch for the connections and bring them to your cardiologist. AFib after drinking, higher morning blood pressure, palpitations, sleep disruption, fatigue.

One warning before you change anything. Heavy daily drinkers, meaning more than 6 to 8 drinks per day for weeks to months, can have serious withdrawal if they stop abruptly, including tremors, anxiety, seizures, and delirium tremens. That is a medical emergency. If you’re drinking at that level, talk to a doctor before stopping. You may need medically supervised detoxification.

Medications and Programs for Alcohol Use Disorder

If you’re drinking more than 14 standard drinks per week as a man or 7 as a woman, or you have signs of dependence such as drinking more or longer than intended, failed cut-back attempts, cravings, tolerance, or withdrawal, professional help substantially improves your odds.

Three medications are FDA-approved for alcohol use disorder and all three are underused. A 2014 JAMA meta-analysis showed naltrexone and acamprosate each roughly double the chance of sustained abstinence versus placebo, with effect sizes comparable to many cardiovascular medications, yet fewer than 10 percent of patients with alcohol use disorder get prescribed any of them in primary care.

Naltrexone is first-line for most patients. It blocks opioid receptors so each drink feels less rewarding and the urge for the next one fades. It comes as a 50 mg pill once daily or a 380 mg extended-release injection (Vivitrol) monthly, which suits patients who struggle with daily adherence. You don’t have to be abstinent already; the Sinclair method has patients keep drinking but take the pill beforehand, gradually extinguishing the urge. Side effects are nausea that usually settles in a week or two, headache, and rarely liver enzyme elevation. Avoid it in severe liver disease or if you take opioid pain medications.

Acamprosate is for patients who have already stopped and want help staying stopped. It modulates glutamate signaling and blunts the post-acute withdrawal symptoms (anxiety, poor sleep, restlessness, low mood) that pull people back 3 to 12 months after quitting. The dose is 666 mg three times a day, side effects are mild and mostly diarrhea and fatigue, and it’s safer than naltrexone in liver disease but needs dose adjustment in kidney disease. You can stay on it even if you drink again.

Disulfiram (Antabuse) is the old one, producing flushing, nausea, vomiting, palpitations, and headache if you drink within 12 to 24 hours of a dose. It works as a deterrent, so it suits patients with a strong external motivator such as a court order or a spouse supervising dosing, and suits self-managed adherence poorly. The dose is 250 to 500 mg once daily. Other side effects include a metallic taste, drowsiness, and rare liver toxicity. It’s contraindicated in severe coronary artery disease, recent stroke, severe psychiatric illness, and pregnancy.

Two off-label options round it out. Topiramate has reasonable evidence, especially alongside anxiety or mood disorders, titrated to 200 to 300 mg per day in divided doses, with cognitive slowing, tingling in the fingers and toes, and weight loss as common side effects. Gabapentin has modest evidence for cutting drinking and improving sleep at 600 to 1800 mg per day divided, and helps when anxiety or insomnia drives relapse.

Medications work best alongside behavioral support, and the strongest evidence is for cognitive behavioral therapy from an addiction-trained therapist, with motivational enhancement therapy, contingency management, and family-based interventions also holding up. Peer support includes Alcoholics Anonymous, SMART Recovery, Refuge Recovery, and Women for Sobriety; the best program is the one you’ll actually attend. Intensive outpatient programs run 9 to 15 hours per week of group therapy over 6 to 12 weeks and are usually covered by insurance. Residential treatment of 28 to 90 days is reserved for more severe cases.

Telling Your Family and Your Cardiologist

Cutting back alone is harder. Family who know what you’re doing keep alcohol out of the house and notice early if you’re slipping. Pick a calm moment and make the asks specific. “My AFib is being made worse by my drinking, so I’m stopping for the next 6 months to see how my numbers respond; please don’t pour me a glass at dinner unless I ask” takes 90 seconds and works. Expect resistance from a spouse who drinks alongside you, and keep it about your cardiac situation rather than a judgment of theirs. If someone actively sabotages the effort, a therapist, an addiction medicine specialist, or an Al-Anon meeting can help.

Bring the same honesty to your cardiology visit, because most patients underreport and we’re not there to judge. “About 6 ounces of wine 5 nights a week plus a couple of glasses on weekends, so probably 14 to 18 standard drinks per week” is far more useful than “a glass of wine with dinner.” Note any binge episodes, mention symptoms you’ve connected to drinking, and say plainly whether you’re aiming to cut back or quit.

Common Questions

Is red wine really good for the heart?

No. The resveratrol doses that show benefit in animal studies are far higher than anyone could drink, and the proposed mechanism doesn’t translate to coronary protection in better-designed studies. Red wine gets no special pass. Neither does beverage type generally, since beer, wine, and spirits all contain ethanol and total alcohol drives the risk. Beverage choice only shifts things at the margins through calorie load, sugar in mixers, and polyphenols in wine.

What about the Mediterranean diet, which includes wine?

Its cardiovascular benefits are well established, and they come from the food, the olive oil, fish, vegetables, legumes, and nuts, and from the overall pattern. Wine is a culturally common component, not a required one. The benefit works without alcohol.

I’m a social drinker at a drink a day. Should I worry?

At one drink a day or less with no binges, the cardiovascular risk is small and the proposed benefit is thought to be absent. Whether to cut further is a personal call based on your overall health, AFib status, blood pressure control, and family history.

If you have questions about how alcohol affects your specific cardiac condition, or need help with drinking that has gotten out of hand, our office can help. To get in touch, visit our practice website. For coordinated care with addiction medicine, we work with the team at San Diego Cardiovascular Associates.

References

1. Biddinger KJ, Emdin CA, Haas ME, et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Netw Open. 2022;5:e223849.

2. AHA Scientific Statement on Alcohol Use and Cardiovascular Health. Circulation. 2025.

3. Voskoboinik A, Kalman JM, De Silva A, et al. Alcohol Abstinence in Drinkers with Atrial Fibrillation (Alcohol-AF). N Engl J Med. 2020;382:20-28.

4. Roerecke M, Tobe SW, Kaczorowski J, et al. Sex-Specific Associations Between Alcohol Consumption and Incidence of Hypertension: A Systematic Review and Meta-Analysis of Cohort Studies. J Am Heart Assoc. 2018;7:e008202.

5. Larsson SC, Wallin A, Wolk A, Markus HS. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med. 2016;14:178.

6. Mostofsky E, Chahal HS, Mukamal KJ, Rimm EB, Mittleman MA. Alcohol and immediate risk of cardiovascular events: a systematic review and dose-response meta-analysis. Circulation. 2016;133:979-987.

7. Bell S, Daskalopoulou M, Rapsomaniki E, et al. Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases. BMJ. 2017;356:j909.

8. Stockwell T, Zhao J, Panwar S, Roemer A, Naimi T, Chikritzhs T. Do “Moderate” Drinkers Have Reduced Mortality Risk? J Stud Alcohol Drugs. 2016;77:185-198.

Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.